<SEC-DOCUMENT>0001193125-23-131536.txt : 20230502
<SEC-HEADER>0001193125-23-131536.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502091602
ACCESSION NUMBER:		0001193125-23-131536
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230501
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCA Healthcare, Inc.
		CENTRAL INDEX KEY:			0000860730
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				273865930
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11239
		FILM NUMBER:		23876878

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLZ
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		6153449551

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLAZA
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA Holdings, Inc.
		DATE OF NAME CHANGE:	20101126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA INC/TN
		DATE OF NAME CHANGE:	20010627

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA THE HEALTHCARE CO
		DATE OF NAME CHANGE:	20010419
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d900328d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hca="http://hcahealthcare.com/20230501" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-05-01_to_2023-05-01">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-05-01_to_2023-05-01">0000860730</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="hca-20230501.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-05-01_to_2023-05-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000860730</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-01</xbrli:startDate> <xbrli:endDate>2023-05-01</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-05-01_to_2023-05-01">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): May&#160;2, 2023 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt:datemonthdayyearen">May 1, 2023</ix:nonNumeric>)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-05-01_to_2023-05-01">HCA Healthcare, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-05-01_to_2023-05-01">001-11239</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-05-01_to_2023-05-01">27-3865930</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-05-01_to_2023-05-01">One Park Plaza</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-05-01_to_2023-05-01">Nashville</ix:nonNumeric>,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-05-01_to_2023-05-01">37203</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-05-01_to_2023-05-01">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-05-01_to_2023-05-01">344-9551</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each Class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-01_to_2023-05-01">Common Stock, $.01 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-01_to_2023-05-01">HCA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-05-01_to_2023-05-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Underwriting Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;1, 2023, HCA Healthcare, Inc. (the &#8220;Registrant&#8221; or the &#8220;Parent Guarantor&#8221;) and HCA Inc., a wholly owned subsidiary of the Registrant (the &#8220;Issuer&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the several underwriters named therein, for the issuance and sale by the Issuer of $3,250,000,000 aggregate principal amount of senior notes (collectively, the &#8220;Notes&#8221;) in the following tranches: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$1,000,000,000 aggregate principal amount of 5.200% Senior Notes due 2028; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$1,250,000,000 aggregate principal amount of 5.500% Senior Notes due 2033; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">$1,000,000,000 aggregate principal amount of 5.900% Senior Notes due 2053. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be guaranteed on a senior unsecured basis by the Parent Guarantor, and will be issued and sold pursuant to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-271537)</span> and a related preliminary prospectus supplement dated May&#160;1, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The description of the Underwriting Agreement is qualified in its entirety by the terms of such agreement, which is incorporated herein by reference and attached to this report as Exhibit 1.1. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d900328dex11.htm">Underwriting Agreement, dated as of May&#160;1, 2023, among HCA Inc., HCA Healthcare, Inc., and BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the other several underwriters named therein. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">HCA HEALTHCARE, INC. (Registrant)</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John M. Franck II</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">John M. Franck II</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Vice President &#8211; Legal and Corporate Secretary</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: May&#160;2, 2023 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d900328dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HCA INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$1,000,000,000
5.200% Senior Notes due 2028 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$1,250,000,000 5.500% Senior Notes due 2033 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$1,000,000,000 5.900% Senior Notes due 2053 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>UNDERWRITING AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May&nbsp;1, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2%; font-size:10pt; font-family:Times New Roman">As Representatives
of the Underwriters </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Bryant
Park </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY&nbsp;10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Citigroup Global Markets
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">388 Greenwich Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10013 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Wells Fargo Securities, LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">550 South Tryon Street, 5th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charlotte, North Carolina
28202 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HCA Inc., a Delaware
corporation (the &#147;<U>Company</U>&#148;), proposes to issue and sell to the several parties named in <U>Schedule I</U> hereto (each an &#147;<U>Underwriter</U>&#148; and together, the &#147;<U>Underwriters</U>&#148;), for whom you (the
&#147;<U>Representatives</U>&#148;) are acting as representatives, the respective amounts set forth in such <U>Schedule&nbsp;I</U> of (i) $1,000,000,000 aggregate principal amount of its 5.200% Senior Notes due 2028 (the &#147;<U>2028
Notes</U>&#148; and, together with the 2028 Guarantee (as defined below), the &#147;<U>2028 Securities</U>&#148;), (ii) $1,250,000,000 aggregate principal amount of its 5.500% Senior Notes due 2033 (the &#147;<U>2033 Notes</U>&#148; and, together
with the 2033 Guarantee (as defined below), the &#147;<U>2033 Securities</U>&#148;) and (iii) $1,000,000,000 aggregate principal amount of its 5.900% Senior Notes due 2053 (the &#147;<U>2053 Notes</U>,&#148; and, together with the 2053 Guarantee (as
defined below), the &#147;<U>2053 Securities</U>&#148;). The 2028 Notes, the 2033 Notes and the 2053 Notes are collectively referred to hereafter as the &#147;<U>Notes</U>&#148; and the 2028 Securities, the 2033 Securities and the 2053 Securities
are collectively referred to hereafter as the &#147;<U>Securities</U>&#148;. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will be issued pursuant to a base indenture, dated August&nbsp;1, 2011, (the &#147;<U>Base
Indenture</U>&#148;) among the Company, HCA Healthcare, Inc., a Delaware corporation and the Company&#146;s parent (the &#147;<U>Parent Guarantor</U>&#148;), Delaware Trust Company (as successor to Law Debenture Trust Company of New York), as
trustee (in such capacity, the &#147;<U>Trustee</U>&#148;), and Deutsche Bank Trust Company Americas, as registrar, paying agent and transfer agent (the &#147;<U>Registrar</U>&#148;), as supplemented by (i)&nbsp;with respect to the 2028 Notes, the
thirty-fourth supplemental indenture relating to the 2028 Notes, to be dated May&nbsp;4, 2023, among the Company, the Parent Guarantor, the Trustee and the Registrar (the Base Indenture as so supplemented, the &#147;<U>Thirty-Fourth Supplemental
Indenture</U>&#148;), (ii) with respect to the 2033 Notes, the thirty-fifth supplemental indenture relating to the 2033 Notes, to be dated May&nbsp;4, 2023, among the Company, the Parent Guarantor, the Trustee and the Registrar (the Base Indenture
as so supplemented, the &#147;<U>Thirty-Fifth Supplemental Indenture</U>&#148;) and (iii)&nbsp;with respect to the 2053 Notes, the thirty-sixth supplemental indenture relating to the 2053 Notes, to be dated May&nbsp;4, 2023, among the Company, the
Parent Guarantor, the Trustee and the Registrar (the Base Indenture as so supplemented, the &#147;<U>Thirty-Sixth Supplemental Indenture</U>&#148; and, together with the Thirty-Fourth Supplemental Indenture and the Thirty-Fifth Supplemental
Indenture, each, an &#147;<U>Indenture</U>&#148; and together, the &#147;<U>Indentures</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2028 Notes will be unconditionally guaranteed on a
senior unsecured basis by the Parent Guarantor (the &#147;<U>2028 Guarantee</U>&#148;). The 2033 Notes will be unconditionally guaranteed on a senior unsecured basis by the Parent Guarantor (the &#147;<U>2033 Guarantee</U>&#148;). The 2053 Notes
will be unconditionally guaranteed on a senior unsecured basis by the Parent Guarantor (the &#147;<U>2053 Guarantee</U>&#148; and, together with the 2028 Guarantee and the 2033 Guarantee, the &#147;<U>Guarantees</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the offer and sale of the Securities, the Company and the Parent Guarantor have prepared and filed with the Securities and Exchange
Commission (the &#147;<U>Commission</U>&#148;) a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-271537),</FONT> which registration statement contains a base prospectus
relating to the debt securities, including the Securities, to be issued from time to time by the Company (the &#147;<U>Base Prospectus</U>&#148;). The Company has also filed or proposed to file, with the Commission pursuant to Rule 424 under the Act
a prospectus supplement specifically relating to the Securities (the &#147;<U>Prospectus Supplement</U>&#148;). Such registration statement, including any required information deemed to be a part thereof at the time of effectiveness pursuant to Rule
430A, 430B or 430C under the Act (the &#147;<U>Rule 430 Information</U>&#148;), is called the &#147;<U>Registration Statement</U>.&#148; The term &#147;<U>Prospectus</U>&#148; shall mean the Base Prospectus as supplemented by the Prospectus
Supplement specifically relating to the Securities in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Act) in connection with the confirmation and sales of the Securities, and the term
&#147;<U>Preliminary Prospectus</U>&#148; means the preliminary prospectus supplement specifically relating to the Securities together with the Base Prospectus. Any reference herein to the Registration Statement, the Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Act as of the effective date of the Registration Statement or the
date of such Preliminary Prospectus or Prospectus as the case may be; any reference to any amendment or supplement to the Registration Statement, the Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents
filed after the date of such Registration Statement, any Preliminary Prospectus or Prospectus, as the case may be, under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (collectively, the
&#147;<U>Exchange Act</U>&#148;), and incorporated by reference in such Registration Statement, any Preliminary Prospectus or Prospectus, as the case may be. The term &#147;<U>Disclosure Package</U>&#148; shall mean (i)&nbsp;a Preliminary Prospectus
dated May&nbsp;1, 2023 (the &#147;<U>Pricing Prospectus</U>&#148;) and (ii)&nbsp;any &#147;free writing prospectus&#148; as defined in Rule 405 of the Act identified in <U>Annex A</U> hereto, which shall include the term sheet prepared pursuant to
Section&nbsp;5 hereto (the &#147;<U>Pricing Term Sheet</U>&#148;), which were available to purchasers of the Securities at or prior to the Applicable Time (as defined herein). For purposes of this Agreement, all references to the Registration
Statement, any Preliminary Prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval system
(&#147;<U>EDGAR</U>&#148;) or its Interactive Data Electronic Applications system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this Agreement, the term &#147;<U>Transaction</U>&#148; means, collectively, the
offering of the Securities and the use of proceeds therefrom described herein and in the Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. As of the date hereof and at the Closing Date (as defined below), the Company
and the Parent Guarantor, jointly and severally, represent and warrant to each Underwriter as follows (unless the context otherwise indicates, references in this Section&nbsp;1 to the &#147;<U>Prospectus</U>&#148; are to (x)&nbsp;the Disclosure
Package in the case of representations and warranties made as of the date hereof and (y)&nbsp;both the Disclosure Package and the Prospectus in the case of representations and warranties made as of the Closing Date): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;No order preventing or suspending the use of any Preliminary Prospectus has been issued by the
Commission, and the Preliminary Prospectus, at the time of filing thereof, complied in all material respects with the Act and did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company and the Parent Guarantor make no representation or warranty with respect to any
statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company or the Parent Guarantor in writing by such Underwriter through the Representatives, expressly for use in any
Preliminary Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;At the Applicable Time, the Disclosure Package did not and, on the
Closing Date, as then amended or supplemented, will not, and the Prospectus as of its date and on the Closing Date will not, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>, that the Company and the Parent Guarantor make no representation or warranty as to the information contained in or omitted from the
Disclosure Package in reliance upon and in conformity with information furnished in writing to the Company or the Parent Guarantor by or on behalf of the Underwriters through the Representatives specifically for inclusion therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company (including its agents and representatives, other than the Underwriters in their capacity
as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#147;written communication&#148; (as defined in Rule 405 under the Act) that constitutes an offer to sell
or solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a communication referred to in clauses (i)&nbsp;(ii) and (iii) below), an &#147;<U>Issuer Free Writing
Prospectus</U>&#148;) other than (i)&nbsp;any document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Act or Rule 134 under the Act, (ii)&nbsp;the Preliminary Prospectus, (iii)&nbsp;the Prospectus, (iv)&nbsp;the documents
identified in <U>Annex A</U> (including the Pricing Term Sheet) and (v)&nbsp;any electronic road show or other written communications, in each case approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus
complied in all material respects with the Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Act (to the extent required thereby) and, at the Applicable Time, when taken together with the Pricing
Prospectus, did not, and at the Closing Date, as then amended or supplemented, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; <U>provided</U> that the Company and the Parent Guarantor make no representation or warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus in
reliance upon and in conformity with information relating to any Underwriter furnished to the Company or the Parent Guarantor in writing by such Underwriter through the Representatives expressly for use in any Issuer Free Writing Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Registration Statement is an &#147;automatic
shelf registration statement&#148; as defined under Rule 405 of the Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such Registration
Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission and no proceeding for
that purpose or pursuant to Section&nbsp;8A of the Act against the Company or related to the offering of the Securities has been initiated or threatened by the Commission; as of the effective date of the Registration Statement, the Registration
Statement complied in all material respects with the Act and the Trust Indenture Act, and did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date, the Prospectus, as then amended or supplemented, will not contain any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company and the Parent Guarantor
make no representation or warranty with respect to (i)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility and Qualification (Form <FONT STYLE="white-space:nowrap">T-1)</FONT> of the Trustee under the Trust
Indenture Act or (ii)&nbsp;any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company or the Parent Guarantor in writing by such Underwriter through the Representatives
expressly for use in the Registration Statement and the Prospectus and any amendment or supplement thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company, the Parent Guarantor or other Significant Subsidiaries (as defined below) is
or, after giving effect to the offering and sale of the Securities and the application of the proceeds thereof as described in each of the Registration Statement, the Disclosure Package and the Prospectus, will be an &#147;investment company&#148;
as defined in the Investment Company Act, without taking account of any exemption arising out of the number of holders of the Company&#146;s securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company, the Parent Guarantor or any of its subsidiaries or any of its Affiliates has
taken or will take, directly or indirectly, any action designed to or that has constituted or that would reasonably be expected to cause or result, under the Exchange Act or otherwise, in stabilization or manipulation of the price of any security of
the Company or any of its subsidiaries to facilitate the sale or resale of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise stated therein, since the respective dates as of which information is given in
any of the Registration Statement, the Disclosure Package or the Prospectus, there has been no material adverse change in the condition (financial or otherwise), business or results of operations of the Company, the Parent Guarantor or their
subsidiaries taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company, the Parent Guarantor and its Significant
Subsidiaries (as defined below) has been duly organized and is validly existing as an entity in good standing under the laws of the jurisdiction in which it is chartered or organized with full corporate or other organizational power and authority to
own or lease, as the case may be, and to operate its properties and conduct its business as described in the Registration Statement, the Disclosure Package and the Prospectus, and is duly qualified to do business as a foreign corporation or other
entity and is in good standing under the laws of each jurisdiction where the ownership or leasing of its properties or the conduct of its business requires such qualification except where the failure to be so organized or qualified, have such power
or authority or be in good standing would not reasonably be expected to have a material adverse effect on the condition (financial or otherwise), business or results of operations of the Company and its subsidiaries, taken as a whole and after
giving effect to the Transaction (a &#147;<U>Material Adverse Effect</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Company does not own or control, directly or
indirectly, any &#147;significant subsidiary,&#148; as defined in Rule <FONT STYLE="white-space:nowrap">1-02(w)</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Act, other than those subsidiaries listed on <U>Annex C</U>
(each, a &#147;<U>Significant Subsidiary</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;As of March&nbsp;31, 2023, on an as
adjusted basis, after giving effect to the consummation of the Transaction, the Company, the Parent Guarantor and its subsidiaries would have had the issued and outstanding capitalization as set forth in each of the Registration Statement, the
Disclosure Package and the Prospectus under the heading &#147;Capitalization&#148; and all the outstanding membership interests or shares of capital stock, as applicable, of the Company, the Parent Guarantor and each Restricted Subsidiary (as such
term is defined under the caption &#147;Description of the Notes&#148; of each of the Disclosure Package and the Prospectus) have been duly authorized and validly issued, are fully paid and nonassessable, if applicable, and were not issued in
violation of any preemptive or similar rights and, except as otherwise set forth in the Registration Statement, the Disclosure Package and the Prospectus, as of the Closing Date, all outstanding shares of capital stock or membership interests of the
subsidiaries held by the Company or the Parent Guarantor are owned either directly or indirectly free and clear of any security interest, claim, lien or encumbrance (other than liens, encumbrances and restrictions imposed in connection with the
senior secured credit facilities (the &#147;Credit Facilities&#148;) of the Company, under the other secured indebtedness set forth in the Registration Statement, the Disclosure Package and the Prospectus under the heading
&#147;Capitalization,&#148; or permitted under the Credit Facilities and the Indentures and by the Act and the state securities or &#147;blue sky&#148; laws of certain jurisdictions). Except as disclosed in the Registration Statement, the Disclosure
Package and the Prospectus, there will be, on the Closing Date and after giving effect to the consummation of the Transaction, no (i)&nbsp;outstanding options, warrants or other rights to purchase, (ii)&nbsp;agreements or other obligations to issue
or (iii)&nbsp;other rights to convert any obligation into, or exchange any securities for, shares of capital stock of or ownership interests in the Company, the Parent Guarantor or any of its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;(i) This Agreement has been duly authorized, executed and delivered by the Company and the Parent
Guarantor; (ii)&nbsp;each of the Indentures, on the Closing Date, will have been duly authorized, executed and delivered by the Company and the Parent Guarantor and, assuming due authorization, execution, and delivery thereof by the Trustee and the
Registrar, will constitute a legally valid and binding instrument enforceable against the Company and the Parent Guarantor in accordance with its terms (in each case subject, as to the enforcement of remedies, to the effects of (x)&nbsp;bankruptcy,
reorganization, insolvency, fraudulent conveyance, moratorium or other laws affecting creditors&#146; rights generally from time to time in effect, (y)&nbsp;general principles of equity (whether considered in a proceeding in equity or at law) and
(z)&nbsp;an implied covenant of good faith and fair dealing (collectively, the &#147;<U>Enforceability Limitations</U>&#148;)); (iii) the Securities, on the Closing Date, will have been duly authorized by the Company and, when executed and
authenticated by the Trustee, or an authenticating agent appointed by the Trustee, in accordance with the provisions of the applicable Indenture and delivered to and paid for by the Underwriters, will have been duly executed and delivered by the
Company and will constitute the legal, valid and binding obligations of the Company, enforceable against the Company and entitled to the benefits of the applicable Indenture (subject to the Enforceability Limitations); and (iv)&nbsp;the Guarantees,
on the Closing Date, will constitute the legal, valid and binding obligations of the Parent Guarantor, enforceable against the Parent Guarantor in accordance with their respective terms and entitled to the benefits of the applicable Indenture
(subject to the Enforceability Limitations). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;The term &#147;<U>Transaction Documents</U>&#148;
refers to this Agreement, the Securities and the Indentures (including the Guarantees contained therein). Each of the Transaction Documents conforms in all material respects to the description thereof in the Registration Statement, the Disclosure
Package and the Prospectus, to the extent described therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;No consent, approval,
authorization or filing with or order of any United States (or any political subdivision thereof) court or governmental agency or body, or to the knowledge of the Company, any <FONT STYLE="white-space:nowrap">non-United</FONT> States court or
governmental agency or body, is required in connection with the execution, delivery and performance of the Transaction Documents (including, without limitation, the issuance of the Securities), except such (i)&nbsp;as may be required under the blue
sky laws of any jurisdiction in which the Securities are offered and sold in connection with the transactions contemplated hereby or (ii)&nbsp;as shall have been obtained or made prior to the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;None of the execution and delivery of the Transaction Documents, the issuance and sale of the
Securities, the issuance of the Guarantees or the consummation of any other of the transactions herein or therein contemplated, or the fulfillment of the terms hereof or thereof will conflict with or result in a breach or violation of or imposition
of any lien, charge or encumbrance upon any property or assets of the Company or the Parent Guarantor pursuant to (i)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement,
obligation, condition, covenant or instrument to which the Company or the Parent Guarantor is a party or bound or to which its or their property is subject; or (ii)&nbsp;any statute, law, rule, regulation, judgment, order or decree of any court,
regulatory body, administrative agency, governmental body, arbitrator or other authority having jurisdiction over the Company or the Parent Guarantor or any of its or their properties, other than in the cases of clauses (i)&nbsp;and (ii), such
breaches, violations, liens, charges, or encumbrances that would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; or result in the violation of the charter, bylaws or any equivalent governance document
of the Company or the Parent Guarantor. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of the Parent
Guarantor and its consolidated subsidiaries included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus comply in all material respects with the applicable requirements of the Act and the Exchange
Act, as applicable, and present fairly in all material respects the consolidated financial position, results of operations and cash flows of the Parent Guarantor and its consolidated subsidiaries as of the dates and for the periods indicated and
have been prepared in conformity with United States generally accepted accounting principles applied on a consistent basis throughout the periods involved (except as otherwise noted therein). The interactive data in eXtensible Business Reporting
Language incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and
guidelines applicable thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in the
Registration Statement, the Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), no action, suit, proceeding, investigation or audit by or before any court or governmental agency, authority or body
or any arbitrator involving the Company, the Parent Guarantor or any of their respective subsidiaries or their respective property is pending or, to the knowledge of the Company, threatened or contemplated that (i)&nbsp;would reasonably be expected
to have a material adverse effect on the performance of the Transaction Documents or the consummation of any of the transactions contemplated thereby or (ii)&nbsp;would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Company, the Parent Guarantor and their respective subsidiaries owns or leases all such
real properties as are necessary to the conduct of their respective operations as currently conducted, except as would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in each of the Registration Statement, the Disclosure Package
and the Prospectus (in each case, exclusive of any amendment or supplement thereto), none of the Company, the Parent Guarantor or any of their respective subsidiaries is in violation or default of (i)&nbsp;any provision of its charter, bylaws or any
equivalent governance document; (ii)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument to which it is a party or bound or to
which its property is subject; or (iii)&nbsp;any statute, law, rule, regulation, judgment, order or decree applicable to the Company, the Parent Guarantor or any their respective subsidiaries of any court, regulatory body, administrative agency,
governmental body, arbitrator or other authority having jurisdiction over the Company, the Parent Guarantor, their respective subsidiaries or any of their respective properties, as applicable, other than in the cases of clauses (i) (if such entity
is not the Company, the Parent Guarantor or another Significant Subsidiary), (ii) and (iii), such violations and defaults that would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;Ernst&nbsp;&amp; Young LLP, who have audited the consolidated financial statements of the Parent
Guarantor and its subsidiaries as of December&nbsp;31, 2022 and 2021 and for each of the three years in the period ended December&nbsp;31, 2022 incorporated by reference in each of the Registration Statement, the Disclosure Package and the
Prospectus, are independent registered public accountants with respect to the Parent Guarantor and its subsidiaries within the meaning of the Act and the rules of the Public Company Accounting Oversight Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in each of the Registration Statement, the Disclosure Package
and the Prospectus (in each case, exclusive of any amendment or supplement thereto), the Company, the Parent Guarantor and their subsidiaries (i)&nbsp;have filed all <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> U.S. federal, state and local tax
returns that are required to be filed or have requested extensions thereof except in any case in which the failure so to file would not reasonably be expected to have a Material Adverse Effect and (ii)&nbsp;have paid all taxes required to be paid by
them and any other tax assessment, fine or penalty levied against them, to the extent that any of the foregoing is due and payable, except for any such tax, tax assessment, fine or penalty that is currently being contested in good faith or as would
not reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;Immediately after giving effect to the
Transaction, no subsidiary of the Parent Guarantor (including for the avoidance of doubt, the Company) will be prohibited, directly or indirectly, from paying any dividends to the Company or the Parent Guarantor or any other subsidiary (except as
may be limited by applicable state or foreign corporation, limited liability company, limited partnership, partnership, insurance or other applicable regulatory law), from making any other distribution on such subsidiary&#146;s capital stock or
membership interests (except as may be limited by applicable state or foreign corporation, limited liability company, limited partnership, partnership, insurance or other applicable regulatory law), from repaying to the Company or the Parent
Guarantor or any other subsidiary any loans or advances to such subsidiary from the Company or the Parent Guarantor or any other subsidiary or from transferring any of such subsidiary&#146;s property or assets to the Company or the Parent Guarantor
or any other subsidiary of the Company or the Parent Guarantor, except as described in each of the Registration Statement, the Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto) or contemplated
pursuant to (i)&nbsp;the Credit Facilities, (ii)&nbsp;the indentures governing the Company&#146;s existing senior notes and (iii)&nbsp;the indentures governing the Parent Guarantor&#146;s senior notes, in each case as described in the Disclosure
Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in each of the Registration
Statement, the Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), (i)&nbsp;the Company, the Parent Guarantor and their respective subsidiaries possess all licenses, certificates, permits and other
authorizations issued by the appropriate U.S. federal, state or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such licenses,
certificates, permits and other authorizations would not reasonably be expected to have a Material Adverse Effect, and (ii)&nbsp;none of the Company, the Parent Guarantor or any of their respective subsidiaries has received any notice of proceedings
relating to the revocation or modification of any such certificate, authorization or permit that, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material Adverse
Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;The Company, the Parent Guarantor and their subsidiaries maintain internal controls
over financial reporting (as defined under Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15</FONT> under the Exchange Act regulations) and a system of internal accounting controls sufficient to provide
reasonable assurances that (A)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorization; (B)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with
United States generally accepted accounting principles and to maintain accountability for assets; (C)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; (D)&nbsp;the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences and (E)&nbsp;the interactive data in eXtensible Business Reporting Language included or
incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and
guidelines applicable thereto. Except as described in the Disclosure Package and the Prospectus, since the end of the Parent Guarantor&#146;s most recent audited fiscal year, (1)&nbsp;the Parent Guarantor is not aware of any material weakness in the
Parent Guarantor&#146;s internal control over financial reporting and (2)&nbsp;there has been no change in the Parent Guarantor&#146;s internal control over financial reporting that, in the cases of clauses (1)&nbsp;and (2), has materially affected,
or is reasonably likely to materially affect, the Parent Guarantor&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;There is and has been no failure on the part of the Parent Guarantor or any of the Parent
Guarantor&#146;s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith (the
&#147;<U>Sarbanes-Oxley Act</U>&#148;), including Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in each of
the Registration Statement, the Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), the Company, the Parent Guarantor and their respective subsidiaries (i)&nbsp;are in compliance with any and all
applicable <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> U.S. federal, state and local laws and regulations relating to the protection of human health and safety (as such is affected by hazardous or toxic substances or wastes (including, without
limitation, medical waste), pollutants or contaminants), the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<U>Environmental Laws</U>&#148;); (ii)&nbsp;have received and are in compliance with all permits,
licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; (iii)&nbsp;have not received notice of any actual or potential liability under any Environmental Law; and (iv)&nbsp;have not
been named as a &#147;potentially responsible party&#148; under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> with
Environmental Laws, failure to receive or comply with required permits, licenses or other approvals, liability or status as a potentially responsible party would not reasonably be expected to, individually or in the aggregate, have a Material
Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;No forward-looking statement (within the meaning of Section&nbsp;27A of the Act
and Section&nbsp;21E of the Exchange Act) or presentation of market-related or statistical data contained in any of the Registration Statement, the Disclosure Package and the Prospectus has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in each of the
Registration Statement, the Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), (i) the Company, the Parent Guarantor and their respective subsidiaries possess all required permits, licenses,
provider numbers, certificates, approvals (including, without limitation, certificate of need approvals), consents, orders, certifications (including, without limitation, certification under the Medicare, Medicaid, TRICARE programs and other
governmental healthcare programs in which they participate), accreditations (including, without limitation, accreditation by The Joint Commission, DNV or The Accreditation Association for Ambulatory Health Care) and other authorizations
(collectively, &#147;<U>Governmental Licenses</U>&#148;) issued by, and have made all required declarations and filings with, the appropriate federal, state, local or foreign regulatory agencies or bodies and accreditation organizations necessary to
conduct the business now operated by them (including, without limitation, Government Licenses as are required (a)&nbsp;under such federal and state healthcare laws as are applicable to the Company, the Parent Guarantor and their respective
subsidiaries and (b)&nbsp;with respect to those facilities operated by the Company, the Parent Guarantor or any of their respective subsidiaries that participate in the Medicare, Medicaid and/or TRICARE programs, to receive reimbursement
thereunder), except where the failure to possess such Governmental Licenses or to make such declarations and filings<B> </B>would not reasonably be expected to result in a Material Adverse Effect; (ii)&nbsp;the Company, the Parent Guarantor and
their respective subsidiaries are in compliance with the terms and conditions of all such Governmental Licenses, except where the failure to so comply would not, individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect; (iii)&nbsp;all of the Governmental Licenses are valid and in full force and effect, except where the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not
reasonably be expected to result in a Material Adverse Effect and (iv)&nbsp;none of the Company, the Parent Guarantor or any of their respective subsidiaries has received any notice of proceedings relating to the revocation or modification of any
such Governmental Licenses which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to result in a Material Adverse Effect. All of the acute care hospitals, psychiatric
hospitals and inpatient rehabilitation facilities operated by the Company, the Parent Guarantor or any of their respective subsidiaries are &#147;providers&#148; (as defined in the Social Security Act and the regulations promulgated thereunder
(collectively, &#147;<U>SSA</U>&#148;)), and all ambulatory surgery centers, diagnostic and imaging centers, radiation and oncology centers and other healthcare operations operated by the Company, the Parent Guarantor or any of their respective
subsidiaries are &#147;suppliers,&#148; as defined in the SSA, and all such providers of services and suppliers are eligible to participate in the Medicare and (to the extent disclosed in the Registration Statement, the Disclosure Package and the
Prospectus) Medicaid and TRICARE programs. For purposes of this Agreement, &#147;<U>Medicaid</U>&#148; means any state-operated means-tested entitlement program under Title XIX of the SSA that provides federal grants to states for medical assistance
based on specific eligibility criteria, &#147;<U>Medicare</U>&#148; means that government-sponsored entitlement program under Title XVIII of the SSA that provides for a health insurance system for eligible elderly and disabled persons including
eligible persons with <FONT STYLE="white-space:nowrap">end-stage</FONT> renal disease and &#147;<U>TRICARE</U>&#148; means the healthcare program established by the U.S. Department of Defense under Title 10, Subtitle A, Part II, Chapter 55 (10
U.S.C. &#167; 1071 <U>et</U> <U>seq</U>.) for members of the military, military retirees and their dependents, and includes the following health plan options: TRICARE Prime, TRICARE Select and TRICARE for Life. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;The accounts receivable of the Company, the
Parent Guarantor and their respective subsidiaries have been adjusted to reflect material changes in the reimbursement policies of third party payors such as Medicare, Medicaid, TRICARE, private insurance companies, health maintenance organizations,
preferred provider organizations, managed care systems and other third party payors (including, without limitation, Blue Cross plans). The accounts receivable relating to such third party payors do not materially exceed amounts the Company, the
Parent Guarantor and their respective subsidiaries are entitled to receive, except as set forth in or contemplated in the Registration Statement, the Disclosure Package or the Prospectus (in each case, exclusive of any amendment or supplement
thereto). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in or contemplated in each of the Registration Statement, the
Disclosure Package and the Prospectus (in each case, exclusive of any amendment or supplement thereto), none of the Company, the Parent Guarantor or, to the knowledge of the Company, any officers, directors, stockholders, members, employees or other
agents of the Company, the Parent Guarantor or any of their respective subsidiaries or any of the hospitals operated by them, has engaged in any activities which are prohibited under federal Medicare and Medicaid statutes, including, but not limited
to, 42 U.S.C. <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7</FONT> (Program Exclusion), <FONT STYLE="white-space:nowrap">Section&nbsp;1320a-7a</FONT> (Civil Monetary Penalties), <FONT STYLE="white-space:nowrap">1320a-7b</FONT> (the
Anti-kickback Statute), Sections 1395nn and 1396b (the &#147;Stark&#148; law, prohibiting certain self-referrals), the federal TRICARE statute, 10 U.S.C. Section&nbsp;1071 <U>et</U> <U>seq</U>., the Federal Civil False Claims Act, 31 U.S.C. Sections
<FONT STYLE="white-space:nowrap">3729-32,</FONT> Federal Criminal False Claims Act, 18 U.S.C. Section&nbsp;287, False Statements Relating to Health Care Matters, 18 U.S.C. Section&nbsp;1035, Health Care Fraud, 18 U.S.C. Section&nbsp;1347, the
privacy, security and transactions provisions of the Health Insurance Portability and Accountability Act of 1996 (Public Law <FONT STYLE="white-space:nowrap">104-191),</FONT> or the federal Food, Drug&nbsp;&amp; Cosmetics Act, 21 U.S.C.
Section&nbsp;360aaa, all of which, as amended, or any regulations promulgated pursuant to such statutes, or related state or local statutes or regulations or any rules of professional conduct, including but not limited to the following:
(i)&nbsp;knowingly and willfully making or causing to be made a false statement or representation of a material fact in any applications for any benefit or payment under the Medicare or Medicaid program or other federal or state healthcare program
or from any third party (where applicable federal or state law prohibits such payments to third parties); (ii) knowingly and willfully making or causing to be made any false statement or representation of a material fact for use in determining
rights to any benefit or payment under the Medicare or Medicaid program or other federal or state healthcare program or from any third party (where applicable federal or state law prohibits such payments to third parties); (iii) failing to disclose
knowledge by a claimant of the occurrence of any event affecting the initial or continued right to any benefit or payment under the Medicare or Medicaid program or other federal or state healthcare program or from any third party (where applicable
federal or state law prohibits such payments to third parties) on its own behalf or on behalf of another, with intent to secure such benefit or payment fraudulently; (iv)&nbsp;knowingly and willfully offering, paying, soliciting or receiving any
remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind (a)&nbsp;in return for referring an individual to a person for the furnishing or arranging for the furnishing of any other item
or service for which payment may be made in whole or in part by Medicare or Medicaid or other federal or state healthcare program or any third party (where applicable federal or state law prohibits such payments to third parties), or (b)&nbsp;in
return for purchasing, leasing or ordering or arranging for or recommending the purchasing, leasing or ordering of any good, facility, service or item for which payment may be made in whole or in part by Medicare or Medicaid or other federal or
state healthcare program or any third party (where applicable federal or state law prohibits such payments to third parties); (v)&nbsp;referring an individual to a person with which it has ownership or certain other financial arrangements or billing
Medicare or Medicaid or any beneficiary of such program or other person for any designated health service or other item or service (where applicable federal law prohibits such referrals); (vi) knowingly and willfully presenting or causing to be
presented a claim for a medical or other item or service that was not provided as claimed, or is for a medical or other item or service and the person knew or should have known the claim was false or fraudulent; (vii)&nbsp;violating any corporate
integrity agreement or other agreement with any government agency (including, without limitation, the United States Department of Justice (&#147;<U>DOJ</U>&#148;) and the Office of Inspector General of the United States Department of Health and
Human Services (&#147;<U>OIG</U>&#148;); and (viii)&nbsp;violating any enforcement initiative instituted by any governmental agency (including, without limitation, the OIG <B></B>and the DOJ), except, in each case set forth in this paragraph, for
any such activities which would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect.) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not an ineligible issuer, and the
Parent Guarantor is a well-known seasoned issuer, in each case as defined in Rule 405 of the Act, in each case, at the times specified in the Act in connection with the offering of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any certificate signed by any officer of the Company, the Parent Guarantor or their respective subsidiaries and delivered to the Representatives or counsel
for the Underwriters in connection with the offering of the Securities and, when issued, the Guarantees, shall be deemed a joint and several representation and warranty by each of the Company, the Parent Guarantor and their respective subsidiaries,
as to matters covered thereby, to each Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase and Sale</U>. Subject to the terms and
conditions and in reliance upon the representations and warranties herein set forth, the Company agrees to issue and sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company (i)&nbsp;at a
purchase price of 99.236%, plus accrued interest, if any, from May&nbsp;4, 2023 to the Closing Date, of the principal amount of the 2028 Notes set forth opposite such Underwriter&#146;s name in Schedule I hereto, (ii)&nbsp;at a purchase price of
99.282%, plus accrued interest, if any, from May&nbsp;4, 2023 to the Closing Date, of the principal amount of the 2033 Notes set forth opposite such Underwriter&#146;s name in Schedule I hereto and (iii)&nbsp;at a purchase price of 95.843%, plus
accrued interest, if any, from May&nbsp;4, 2023 to the Closing Date, of the principal amount of the 2053 Notes set forth opposite such Underwriter&#146;s name in Schedule I hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery and Payment</U>. Delivery of and payment for the
Securities shall be made at the offices of Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP, One Liberty Plaza, New York, New&nbsp;York 10006, New York City<B> </B>time on May&nbsp;4, 2023 or at such time on such later date not more than three Business
Days after the foregoing date as the Representatives shall designate, which date and time may be postponed by agreement between the Representatives and the Company or as provided in Section&nbsp;10 hereof (such date and time of delivery and payment
for the Securities being herein called the &#147;<U>Closing Date</U>&#148;). Delivery of the Securities shall be made to the Representatives for the respective accounts of the several Underwriters against payment by the several Underwriters through
the Representatives of the purchase price thereof to or upon the order of the Company by wire transfer payable in <FONT STYLE="white-space:nowrap">same-day</FONT> funds to the account specified by the Company in writing to the Representatives.
Delivery of the Securities shall be made through the facilities of The Depository Trust Company (&#147;<U>DTC</U>&#148;) unless the Representatives shall otherwise instruct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Offering by Underwriters</U>. Each Underwriter acknowledges that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;it has not used and will not use, authorize use of, refer to, or participate in the planning for use
of, any &#147;free writing prospectus&#148; as defined under Rule 405 of the Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any
press release issued by the Company), other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such Underwriter, would not trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule 433
under the Act, (ii)&nbsp;any Issuer Free Writing Prospectus listed in <U>Annex B</U> or prepared pursuant to Section&nbsp;1(c) above or Section&nbsp;5(d) below (including any electronic road show), or (iii)&nbsp;any free writing prospectus prepared
by such Underwriter and approved by the Company in advance in writing. Notwithstanding the foregoing, the Underwriters may use a Pricing Term Sheet substantially in the form of <U>Annex&nbsp;A</U> hereto; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;it is not subject to any proceeding under Section&nbsp;8A of the Act with respect to the offering
(and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period (as defined below)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreements</U>. The Company and the Parent Guarantor jointly and severally agree, in each case with each
Underwriter as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company will file the final Prospectus with the Commission within
the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C under the Act, will file any Issuer Free Writing Prospectus (including the Pricing Term Sheet in the form of <U>Annex A</U> hereto) to the extent required by Rule 433 under the
Act; and will file all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus
and for so long as a prospectus relating to the Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the Act (such period, the &#147;<U>Prospectus Delivery Period</U>&#148;); and the Company will
furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered, electronically or otherwise) to the Underwriters in New York City on the second Business Day succeeding the date of this Agreement in
such quantities as the Representatives may reasonably request. The Company will pay the registration fees for this offering within the time period required by Rule 456(b)(1)(i) under the Act (without giving effect to the proviso therein) and in any
event prior to the Closing Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;(i) The Company has furnished or will deliver to
the Representatives and counsel for the Underwriters, without charge, signed copies of the Registration Statement as originally filed and each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates
of experts, and will also deliver to the Representatives, without charge, a conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) for each of the Underwriters. The copies of the Registration
Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T.</FONT> The Company has delivered to each Underwriter, without charge, as many copies of each Preliminary Prospectus as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies
for purposes permitted by the Act and (ii)&nbsp;the Company will furnish to each Underwriter, without charge, during the Prospectus Delivery Period, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may
reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Prior to the later of the Closing
Date or the end of the Prospectus Delivery Period, before making, preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement (other
than an amendment or supplement filed in connection with the registration of additional classes of securities of the Company, the Parent Guarantor and their subsidiaries) or the Prospectus, the Company will furnish to the Representatives and counsel
for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus required to be filed or file
any such proposed amendment or supplement to which the Representatives reasonably object. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The
Company will advise the Representatives promptly, and confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed (other than an amendment or supplement filed in connection with the registration of
additional classes of securities of the Company, Parent Guarantor and their subsidiaries); (ii) when any supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus has been filed; (iii)&nbsp;of any request
by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration Statement or any other request by the Commission for
any additional information; (iv)&nbsp;of the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or
threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Act; (v)&nbsp;of the occurrence of any event within the Prospectus Delivery Period as a result of which any Issuer Free Writing Prospectus as then amended or
supplemented would include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when such Issuer Free
Writing Prospectus is delivered to a purchaser, not misleading; (vi)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule
401(g)(2) under the Act; and (vii)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose; and the Company will use every reasonable effort to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or
suspending any such qualification of the Securities and, if any such order is issued, will obtain as soon as possible the withdrawal thereof as may be necessary to permit offers and sales of the Securities by the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;If at any time prior to the Closing Date
(i)&nbsp;any event shall occur or condition shall exist as a result of which, in the opinion of counsel for the Underwriters or the Company, the Disclosure Package as then amended or supplemented would include any untrue statement of a material fact
or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Disclosure Package to comply with law, the Company will
promptly notify the Representatives thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate,
such amendments or supplements to the Disclosure Package as may be necessary so that the statements in the Disclosure Package as so amended or supplemented will not, in the light of the circumstances, be misleading or so that the Disclosure Package
will comply with law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;If during the Prospectus Delivery Period (i)&nbsp;any event shall occur
or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will promptly notify
the Representatives thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the
Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will
comply with law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company will use reasonable best efforts to assist the Underwriters in
arranging, if necessary, for the qualification of the Securities for sale by the Underwriters under the applicable securities laws of such jurisdictions in the United States as the Representatives may designate and will maintain such qualifications
in effect so long as required for the sale of the Securities; <U>provided</U> that in no event shall the Company or the Parent Guarantor be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any
action that would reasonably be expected to subject it to service of process in suits, other than those arising out of the offering or sale of the Securities, in any jurisdiction where it is not now so subject or to subject themselves to taxation in
excess of a nominal amount in respect of doing business in any jurisdiction. The Company will promptly advise the Representatives of the receipt by it of any notification with respect to the suspension of the qualification of the Securities or the
Guarantees for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company will cooperate with the Representatives and use its commercially reasonable efforts to
permit the Securities to be eligible for clearance and settlement through DTC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Company will
not, for a period following the date of the Prospectus until the Closing Date, without the prior written consent of the Representatives, offer, sell or contract to sell, pledge or otherwise dispose of (or enter into any transaction that is designed
to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company, the Parent Guarantor or any of their respective Affiliates or any
person in privity with the Company, the Parent Guarantor or any of their respective Affiliates), directly or indirectly, or announce the offering of, any capital markets debt securities issued or guaranteed by the Company or the Parent Guarantor
(other than the Securities and the Guarantees). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;The Company and the Parent Guarantor jointly and
severally agree to pay the costs and expenses incident to the following matters: (i)&nbsp;the fees of the Trustee (and its counsel); (ii)&nbsp;the preparation, printing (or reproduction), delivery (including postage, air freight charges and charges
for counting and packaging) and filing under the Act, of such copies of the Registration Statement, the Disclosure Package, and Issuer Free Writing Prospectus and the Prospectus, and all amendments or supplements to either of them, as may, in each
case, be reasonably requested for use in connection with the offering and sale of the Securities; (iii)&nbsp;any stamp or transfer taxes in connection with the original issuance and sale of the Securities; (iv)&nbsp;the printing (or reproduction)
and delivery of any blue sky memorandum to investors in connection with the offering of the Securities; (v)&nbsp;any registration or qualification of the Securities for offer and sale under the securities or blue sky laws of the several states and
any other jurisdictions specified pursuant to Section&nbsp;5(g) (including filing fees and the reasonable fees and expenses of counsel for the Underwriters relating to such registration and qualification); (vi) the approval of the Securities for
book-entry transfer by DTC;<B> </B>(vii)&nbsp;the transportation and other expenses incurred by or on behalf of representatives of the Company in connection with presentations to prospective purchasers of the Securities; (viii)&nbsp;the fees and
expenses of the Company&#146;s and the Parent Guarantor &#146;s accountants and the fees and expenses of counsel (including local and special counsel) to the Company; (ix)&nbsp;the rating of the Securities by rating agencies; and (x)&nbsp;all other
costs and expenses incident to the performance by the Company of their obligations hereunder; <U>provided</U>, <U>however</U>, that except as specifically provided in this paragraph (j), in Section&nbsp;8 and in Section&nbsp;9, the Underwriters
shall pay their own costs and expenses in connection with presentations for prospective purchasers of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company will use the proceeds from the sale of the Securities in the manner described in each of
the Registration Statement, the Disclosure Package and the Prospectus under the caption &#147;Use of Proceeds.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;The Company and the Parent Guarantor jointly and severally acknowledge and agree that the
Underwriters are acting solely in the capacity of an arm&#146;s length contractual counterparty to the Company and the Parent Guarantor with respect to the offering of Securities contemplated hereby (including in connection with determining the
terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company, the Parent Guarantor or any other person. Additionally, no Underwriter is advising the Company, the Parent Guarantor or any other person as to any
legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company and the Parent Guarantor shall consult with their own advisors concerning such matters and shall be responsible for making their own independent investigation
and appraisal of the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company or the Parent Guarantor with respect thereto. Any review by the Underwriters of the Company and the Parent
Guarantor, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company or the Parent Guarantor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp; The Company will, pursuant to reasonable
procedures developed in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions to the Obligations of the Underwriters</U>. The obligations of the Underwriters to purchase the
Securities shall be subject to the accuracy in all material respects (except to the extent already qualified by materiality, in which case such obligations shall be subject to the accuracy in all respects) of the representations and warranties of
the Company and the Parent Guarantor contained herein at the Applicable Time, to the accuracy in all material respects (except to the extent already qualified by materiality, in which case such obligations shall be subject to the accuracy in all
respects) of the representations and warranties of the Company and the Parent Guarantor contained herein at the Closing Date, to the accuracy of the statements of the Company or the Parent Guarantor made in any certificates pursuant to the
provisions hereof, to the performance by the Company of its obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;No order suspending the effectiveness of the Registration Statement shall be in effect, and no
proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section&nbsp;8A under the Act shall be pending before or threatened by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with
the Commission under the Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Act) and in accordance with Section&nbsp;5(a) hereof; and all requests by the Commission for additional information shall
have been complied with to the reasonable satisfaction of the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company
shall have requested and caused Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP, counsel for the Company, to furnish to the Underwriters an opinion letter and a negative assurance letter, each dated the Closing Date and substantially in the forms of
<U>Exhibit A</U> and <U>Exhibit&nbsp;B</U>, respectively, hereto and an opinion of Bass, Berry&nbsp;&amp; Sims PLC, special regulatory counsel for the Company, dated the Closing Date and substantially in the form of <U>Exhibit C</U> hereto. The
Company shall have requested and caused the chief legal offier of the Company to furnish to the Underwriters an opinion letter dated the Closing Date with regards to such matters as the Representatives shall reasonably require. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Underwriters shall have received from Cahill Gordon&nbsp;&amp; Reindel <SMALL>LLP</SMALL>,
counsel for the Underwriters, such opinion letter and advice letter, each dated the Closing Date and addressed to the Underwriters, with respect to the issuance and sale of the Securities, the Indentures, the Disclosure Package and the Prospectus
(as amended or supplemented at the Closing Date) and other related matters as the Underwriters may reasonably require; and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to
pass upon such matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have furnished to the Underwriters a certificate of
the Company, signed by (x)&nbsp;the chairman, chief executive officer, president or vice president and (y)&nbsp;the chief financial officer, treasurer or principal financial or accounting officer of the Company, dated the Closing Date, to the effect
that the signers of such certificate have carefully examined the Disclosure Package and the Prospectus, any amendment or supplement to the Disclosure Package or the Prospectus and this Agreement and that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;the representations and warranties of the Company and the Parent Guarantor in this Agreement are
true and correct in all material respects (except to the extent already qualified by materiality, in which case such representations and warranties are true and correct in all respects) at the Applicable Time and on the Closing Date, and the Company
and the Parent Guarantor have complied in all material respects with all the agreements and satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;since the date of the most recent financial
statements included or incorporated by reference in each of the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto), there has been no material adverse change in the condition (financial or otherwise), business
or results of operations of the Company and its subsidiaries, taken as a whole, except as set forth in or contemplated in the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;At the Applicable Time and at the Closing Date, the Parent Guarantor shall have requested and caused
Ernst&nbsp;&amp; Young LLP to furnish to the Underwriters a &#147;comfort&#148; letter, dated as of the Applicable Time, and a bring-down &#147;comfort letter,&#148; dated as of the Closing Date, respectively, in form and substance reasonably
satisfactory to the Representatives, confirming that they are independent registered public accountants within the meaning of the Exchange Act and within the meaning of the rules of the Public Company Accounting Oversight Board and confirming
certain matters with respect to the audited and unaudited financial statements and other financial and accounting information contained in the Registration Statement, the Disclosure Package and the Prospectus, including any amendment or supplement
thereto at the date of the applicable letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Subsequent to the Applicable Time or, if earlier,
the dates as of which information is given in the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto), there shall not have been any change or development in the condition (financial or otherwise), business or
results of operations of the Parent Guarantor and its subsidiaries, taken as a whole, and after giving effect to the Transaction, except as set forth in or contemplated in the Disclosure Package and the Prospectus (exclusive of any amendment or
supplement thereto), the effect of which is, or would reasonably be expected to become, in the judgment of the Representatives, so material and adverse as to make it impractical or inadvisable to proceed with the offering, sale or delivery of the
Securities on the terms and in the manner contemplated in the Registration Statement, the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing Date, the Company, the Parent Guarantor and the Trustee shall have entered into the
applicable Indenture, and the Representatives shall have received counterparts, conformed as executed, thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;Subsequent to the Applicable Time, there shall not have been any decrease in the rating of the
Securities by any &#147;nationally recognized statistical rating organization,&#148; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act, or any notice given of any intended or potential decrease in any such rating or of a possible
change in any such rating that does not indicate the direction of the possible change. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Prior to
the Closing Date, the Company shall have furnished to the Representatives such further information, certificates and documents as the Representatives may reasonably request, as set forth in the closing memorandum relating to the offering of the
Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;Prior to the Closing Date, the Company shall have
taken all action reasonably required to be taken by it to have the Securities declared eligible for clearance and settlement through DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All opinions,
letters, evidence and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to the Representatives and counsel for
the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The documents required to be delivered by this Section&nbsp;6 will be available for inspection at the office of Cleary Gottlieb
Steen&nbsp;&amp; Hamilton LLP, at One Liberty Plaza, New York, New York 10006, on the Business Day prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;[Reserved]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Reimbursement of Expenses</U>. If the sale of the Securities provided for herein is not consummated because any
condition to the obligations of the Underwriters set forth in Section&nbsp;6 hereof is not satisfied, because of any termination pursuant to Section&nbsp;11 hereof or because of any refusal, inability or failure on the part of the Company or the
Parent Guarantor to perform any agreement herein or to comply with any provision hereof other than by reason of a default by any of the Underwriters, including as described in Section&nbsp;10 hereof, the Company and the Parent Guarantor, jointly and
severally, will reimburse the Underwriters through the Representatives on behalf of the Underwriters on demand for all reasonable expenses (including reasonable fees and disbursements of Cahill Gordon&nbsp;&amp; Reindel <SMALL>LLP</SMALL>) that
shall have been incurred by them in connection with the proposed purchase and sale of the Securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification and Contribution</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company and the Parent Guarantor jointly and severally agree to indemnify and hold harmless each Underwriter,
the directors, officers, employees, agents and Affiliates of each Underwriter and each person who controls any Underwriter within the meaning of either the Act or the Exchange Act against any and all losses, claims, damages or liabilities, joint or
several, to which they or any of them may become subject under the Act, the Exchange Act or other U.S. federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) arise out of or are based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any omission or alleged omission to state therein a material fact required to be
stated therein or necessary in order to make the statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), the
Disclosure Package, any Issuer Free Writing Prospectus or any written communication that constitutes an offer to sell or a solicitation of any offer to buy the Securities used by the Company or the Parent Guarantor in violation of the provisions of
this Agreement, or the omission or alleged omission to state therein a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, and agree (subject to the limitations set
forth in the proviso to this sentence) to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by it in connection with investigating or defending any such loss, claim, damage, liability or action;
<U>provided</U>, <U>however</U>, that the Company and the Parent Guarantor will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue
statement or omission or alleged omission made in the Registration Statement, the Prospectus (or any amendment or supplement thereto), the Disclosure Package or any Issuer Free Writing Prospectus in reliance upon and in conformity with written
information furnished to the Company or the Parent Guarantor by or on behalf of any Underwriter through the Representatives specifically for inclusion therein. This indemnity agreement will be in addition to any liability that the Company and the
Parent Guarantor may otherwise have. Each indemnifying party shall not be liable under this Section&nbsp;9 to any indemnified party regarding any settlement or compromise or consent to the entry of any judgment with respect to any pending or
threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement,
compromise or consent is consented to by such indemnifying party, which consent shall not be unreasonably withheld. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Each Underwriter severally, and not jointly, agrees to indemnify
and hold harmless (i)&nbsp;the Company and the Parent Guarantor, (ii)&nbsp;each person, if any, who controls (within the meaning of either the Act or the Exchange Act) the Company or the Parent Guarantor, and (iii)&nbsp;the directors and officers of
the Company and the Parent Guarantor, to the same extent as the foregoing indemnity from the Company and the Parent Guarantor, to each Underwriter, but only with reference to written information relating to such Underwriter furnished to the Company
or the Parent Guarantor by or on behalf of such Underwriter through the Representatives specifically for inclusion in the Registration Statement, the Prospectus (or any amendment or supplement thereto), the Disclosure Package or any Issuer Free
Writing Prospectus. This indemnity agreement will be in addition to any liability that any Underwriter may otherwise have. The Company and the Parent Guarantor acknowledge that the fifth, tenth and eleventh paragraphs and the second sentence of the
seventh paragraph under the heading &#147;Underwriting (Conflicts of Interest)&#148; in the Disclosure Package and the Prospectus constitute the only information furnished in writing by or on behalf of the Underwriters for inclusion in the
Registration Statement, the Prospectus (or any amendment or supplement thereto), the Disclosure Package or any Issuer Free Writing Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Promptly after receipt by an indemnified party under this Section&nbsp;9 of notice of the commencement of any
action, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section&nbsp;9, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the
indemnifying party (i)&nbsp;will not relieve it from liability under paragraph&nbsp;(a) or (b)&nbsp;above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of
substantial rights or defenses and (ii)&nbsp;will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a)&nbsp;or (b) above, except as
provided in paragraph (d)&nbsp;below. The indemnifying party shall be entitled to appoint counsel (including local counsel) of the indemnifying party&#146;s choice at the indemnifying party&#146;s expense to represent the indemnified party in any
action for which indemnification is sought (in which case the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel, other than local counsel if not appointed by the indemnifying party, retained by
the indemnified party or parties except as set forth below); <U>provided</U>, <U>however</U>, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party&#146;s election to appoint counsel
(including local counsel) to represent the indemnified party in an action, the indemnified party shall have the right to employ separate counsel (including local counsel), and the indemnifying party shall bear the reasonable fees, costs and expenses
of such separate counsel if (i)&nbsp;the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel with a conflict of interest (based on the advice of counsel to the indemnified person);
(ii)&nbsp;such action includes both the indemnified party and the indemnifying party, and the indemnified party shall have reasonably concluded (based on the advice of counsel to the indemnified person) that there may be legal defenses available to
it and/or other indemnified parties that are different from or additional to those available to the indemnifying party; (iii)&nbsp;the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent
the indemnified party within a reasonable time after notice of the institution of such action; or (iv)&nbsp;the indemnifying party shall authorize the indemnified party to employ separate counsel at the expense of the indemnifying party. It is
understood and agreed that the indemnifying person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the reasonable fees and expenses of more than one separate firm (in addition to any local
counsel) for all indemnified persons. Any such separate firm for any Underwriter, its Affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives, and any such separate firm
for the Company or the Parent Guarantor and any control persons, officers or directors of the Company or the Parent Guarantor shall be designated in writing by the Company or the Parent Guarantor, as the case may be. In the event that any
Underwriter, its Affiliates, directors and officers, employees or any control persons of such Underwriter are indemnified persons collectively entitled, in connection with a proceeding in a single jurisdiction, to the payment of fees and expenses of
a single separate firm under this Section&nbsp;9(c), and any such Underwriter, its Affiliates, directors and officers, employees or any control persons of such Underwriter cannot agree to a mutually acceptable separate firm to act as counsel
thereto, then such separate firm for all such indemnified persons shall be designated in writing by the Representatives. An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to
the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties
to such claim, action, suit or proceeding) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding and does not include any
statement as to, or any admission of, fault, culpability or failure to act by or on behalf of any indemnified party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;In the event that the indemnity provided in paragraph&nbsp;(a) or
(b)&nbsp;of this Section&nbsp;9 is unavailable to or insufficient to hold harmless an indemnified party for any reason (other than by virtue of the failure of an indemnified party to notify the indemnifying party of its right to indemnification
pursuant to subsection (a)&nbsp;or (b) above, where such failure materially prejudices the indemnifying party (through the forfeiture of substantial rights or defenses)), the Company and the Parent Guarantor, on the one hand, and the Underwriters,
on the other hand, severally agree to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending any loss, claim, damage, liability or
action) (collectively &#147;<U>Losses</U>&#148;) to which the Company or the Parent Guarantor and one or more of the Underwriters may be subject in such proportion as is appropriate to reflect the relative benefits received by the Company and the
Parent Guarantor, on the one hand, and by the Underwriters, on the other hand, from the offering of the Securities. If the allocation provided by the immediately preceding sentence is unavailable for any reason or not permitted by applicable law,
the Company and the Parent Guarantor, on the one hand, and the Underwriters, on the other hand, severally shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of the Company and
the Parent Guarantor, on the one hand, and the Underwriters, on the other hand, in connection with the statements or omissions that resulted in such Losses, as well as any other relevant equitable considerations. Benefits received by the Company and
the Parent Guarantor shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by them, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and
commissions received by them. Relative fault shall be determined by reference to, among other things, whether any untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to
information provided by the Company or the Parent Guarantor, on the one hand, or the Underwriters, on the other hand, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue
statement or omission and any other equitable considerations appropriate in the circumstances. The Company and the Parent Guarantor and the Underwriters agree that it would not be just and equitable if the amount of such contribution were determined
by pro rata allocation or any other method of allocation that does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph&nbsp;(d), no person guilty of fraudulent misrepresentation
(within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. Notwithstanding the provisions of this Section&nbsp;9, in no event under this
Section&nbsp;9(d) shall any Underwriter be responsible for any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Securities exceeds the amount of
any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact. The Underwriters&#146; obligations to contribute
pursuant to this Section&nbsp;9 are several in proportion to their respective purchase obligations hereunder and not joint. For purposes of this Section&nbsp;9, each person, if any, who controls an Underwriter within the meaning of either the Act or
the Exchange Act and each director, officer, employee, Affiliate and agent of an Underwriter shall have the same rights to contribution as such Underwriter, and each person who controls the Company or the Parent Guarantor within the meaning of
either the Act or the Exchange Act and the respective officers and directors of the Company and the Parent Guarantor shall have the same rights to contribution as the Company and the Parent Guarantor, subject in each case to the applicable terms and
conditions of this paragraph&nbsp;(d). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Default by an Underwriter</U>. (a)&nbsp;If any one or more
Underwriters shall fail to purchase and pay for the Securities agreed to be purchased by such Underwriter hereunder, and such failure to purchase shall constitute a default in the performance of its or their obligations under this Agreement, the
remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions that the principal amount of the Securities set forth opposite their names in <U>Schedule</U><U></U><U>&nbsp;I</U> hereto bear to the aggregate
principal amount of the Securities set forth opposite the names of all the remaining Underwriters) the Securities which the defaulting Underwriter or Underwriters agreed but failed to purchase; <U>provided</U>, <U>however</U>, that in the event that
the aggregate principal amount of the Securities that the defaulting Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the aggregate principal amount of Securities set forth in <U>Schedule</U><U></U><U>&nbsp;I</U> hereto,
the Company shall be entitled to a period of 36 hours within which to procure another party or parties reasonably satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, as the case may be, to purchase no less than
the amount of such unpurchased Securities that exceeds 10% of the principal amount thereof upon such terms herein set forth. If, however, the Company shall not have completed such arrangements within 72 hours after such default and the principal
amount of unpurchased Securities exceeds 10% of the principal amount of such Securities to be purchased on such date, then this Agreement will terminate without liability to any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or
the Company. In the event of a default by any Underwriter as set forth in this Section&nbsp;10, the Closing Date shall be postponed for such period, not exceeding five Business Days, to effect any changes that in the opinion of counsel for the
Company or counsel for the Representatives are necessary in the Registration Statement and the Prospectus or in any other documents or arrangements. Nothing contained in this Agreement shall relieve any defaulting Underwriter of its liability, if
any, to the Company or any nondefaulting Underwriter for damages occasioned by its default hereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Recognition of the U.S.
Special Resolution Regimes</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S.
Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution
Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special
Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this Section&nbsp;10(b): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>BHC Act Affiliate</U>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C.
&#167; 1841(k). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Covered Entity</U>&#148; means any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Default Right</U>&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12
C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>U.S. Special Resolution Regime</U>&#148; means each of (i)&nbsp;the Federal Deposit
Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. This Agreement shall be subject to termination in the absolute discretion of the
Representatives, by notice given to the Company prior to delivery of and payment for the Securities, if at any time prior to such time (i)&nbsp;trading in any securities generally or trading of any securities issued or guaranteed by the Company or
the Parent Guarantor on the New York Stock Exchange or the NASDAQ Global Market shall have been suspended or materially limited or minimum prices shall have been established on such exchange or the NASDAQ Global Market; (ii)&nbsp;a banking
moratorium shall have been declared either by U.S. federal or New York state authorities;<B> </B>or (iii)&nbsp;there shall have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war or
other calamity or crisis the effect of which on financial markets is such as to make it, in the judgment of the Representatives, impractical or inadvisable to proceed with the offering, sale or delivery of the Securities as contemplated in the
Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Indemnities to Survive</U>. The respective agreements, representations, warranties, indemnities and other statements of the Company and the Parent Guarantor or their respective officers and of the Underwriters set forth in or made pursuant to
this Agreement will remain in full force and effect, regardless of any investigation made by or on behalf of the Underwriters or the Company and the Parent Guarantor, or any of the indemnified persons referred to in Section&nbsp;9 hereof, and will
survive delivery of and payment for the Securities. The provisions of Sections&nbsp;5(j), 8 and 9 hereof shall survive the termination or cancellation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All communications hereunder will be in writing and effective only on receipt and, if sent to the
Representatives, will be mailed, delivered or faxed to BofA Securities Inc., 114 West 47th Street, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NY8-114-07-01,</FONT></FONT></FONT> New York, NY
10036, Attention: High Grade Debt Capital Markets Transaction Management/Legal, fax no.: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(212)-901-7881,</FONT></FONT> to Citigroup Global Markets Inc., at 388 Greenwich Street, New
York, NY 10013, Attention: General Counsel, to J.P. Morgan Securities LLC, 383 Madison Avenue, 3rd Floor, New York, NY 10179, Attention: Syndicate Desk, and to Wells Fargo Securities, LLC, 550 South Tryon Street, 5th Floor, Charlotte, North Carolina
28202, Attention: Transaction Management, Email: tmgcapitalmarkets@wellsfargo.com, or, if sent to the Company or the Parent Guarantor, will be mailed, delivered or faxed c/o HCA Inc. (fax no.: (615) <FONT STYLE="white-space:nowrap">344-1531)</FONT>
and confirmed to it at One Park Plaza, Nashville, Tennessee 37203, Attention: General Counsel, with a copy to David Lopez, Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP, One Liberty Plaza, New York, New York 10006 (fax no.: (212) <FONT
STYLE="white-space:nowrap">225-3999).</FONT> The Company shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors</U>. This Agreement will inure to the benefit of
and be binding upon the parties hereto and at and after the Closing Date, the Company and the Parent Guarantor and their respective successors and the indemnified persons referred to in Section&nbsp;9 hereof and their respective successors and no
other person will have any right or obligation hereunder. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by reason of such purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Applicable Law</U>. THIS AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS
AGREEMENT WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED WITHIN THE STATE OF NEW YORK. THE PARTIES HERETO EACH HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY
ACTION, PROCEEDING OR COUNTERCLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This
Agreement may, if agreed by the Representatives, be in the form of an Electronic Record and may be executed using Electronic Signatures (including, without limitation, facsimile and .pdf) and shall be considered an original, and shall have the same
legal effect, validity and enforceability as a paper record.&nbsp;This Agreement may be executed in as many counterparts as necessary or convenient, including both paper and electronic counterparts, but all such counterparts are one and the same
Agreement. For the avoidance of doubt, the authorization under this paragraph may include, without limitation, use or acceptance by the Representatives of a manually signed paper Communication which has been converted into electronic form (such as
scanned into PDF format), or an electronically signed Communication converted into another format, for transmission, delivery and/or retention. Notwithstanding anything contained herein to the contrary, the Representatives are under no obligation to
accept an Electronic Signature in any form or in any format unless expressly agreed to by the Representatives pursuant to procedures approved by them; provided, further, without limiting the foregoing, (a)&nbsp;to the extent the Representatives have
agreed to accept such Electronic Signature, the Representatives shall be entitled to rely on any such Electronic Signature without further verification and (b)&nbsp;upon the request of the Representatives any Electronic Signature shall be promptly
followed by a manually executed, original counterpart. For purposes hereof, (x) &#147;Communication&#148; means this Agreement, any Transaction Documents and any document, amendment, approval, consent, information, notice, certificate, request,
statement, disclosure or authorization related to any Transaction Documents &#147;Electronic Record&#148; and (y) &#147;Electronic Signature&#148; shall have the meanings assigned to them, respectively, by 15 USC &#167;7006, as it may be amended
from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The section headings used herein are for convenience only and shall not
affect the construction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. The terms that follow, when used in this Agreement, shall
have the meanings indicated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Act</U>&#148; shall mean the Securities Act of 1933, as amended, and the rules and
regulations of the Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; shall have the meaning specified in Rule&nbsp;501(b)
of Regulation&nbsp;D. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; shall mean this underwriting agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Applicable Time</U>&#148; shall mean 4:40 PM, Eastern Time on May&nbsp;1, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; shall mean any day other than a Saturday, a Sunday or a legal holiday or a day on which commercial banking
institutions or trust companies are authorized or required by law to close in New York City. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Commission</U>&#148; shall mean the
Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; shall mean the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investment Company Act</U>&#148; shall mean the Investment
Company Act of 1940, as amended, and the rules and regulations of the Commission promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>subsidiary</U>&#148;
means &#147;Subsidiary&#148; as defined in the Registration Statement, the Disclosure Package and the Prospectus under the captions &#147;Description of the Notes.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trust Indenture Act</U>&#148; shall mean the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission
promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding of our agreement, please sign and
return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement between the Company and the several Underwriters. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">HCA INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John M. Hackett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>John M. Hackett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Senior Vice President &#150; Finance&nbsp;&amp; Treasurer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">HCA HEALTHCARE, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John M. Hackett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>John M. Hackett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Senior Vice President &#150; Finance&nbsp;&amp; Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Underwriting Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The foregoing Agreement is hereby confirmed and accepted as of the date first above written.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BOFA SECURITIES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For itself and as a Representative of the several Underwriters named in <U>Schedule&nbsp;I</U> to the foregoing Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>BOFA SECURITIES, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Douglas Muller</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Douglas Muller</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Underwriting Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The foregoing Agreement is hereby confirmed and accepted as of the date first above written.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For itself and as a Representative of the several Underwriters named in <U>Schedule&nbsp;I</U> to the foregoing Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian D. Bednarski</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brian D. Bednarski</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Underwriting Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The foregoing Agreement is hereby confirmed and accepted as of the date first above written.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For itself and as a Representative of the several Underwriters named in <U>Schedule&nbsp;I</U> to the foregoing Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Som Bhattacharyya</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Som Bhattacharyya</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Executive Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Underwriting Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The foregoing Agreement is hereby confirmed and accepted as of the date first above written.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">For itself and as a Representative of the several Underwriters named in <U>Schedule&nbsp;I</U> to the foregoing Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carolyn Hurley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Carolyn Hurley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Underwriting Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>SCHEDULE&nbsp;I </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Underwriters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal Amount<br>of 2028 Notes<br>to be<br>Purchased</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal Amount<br>of 2033 Notes<BR>to be<br>Purchased</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Principal Amount<br>of 2053 Notes<BR>to be<br>Purchased</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capital One Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Credit Agricole Securities (USA) Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fifth Third Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scotia Capital (USA) Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CIBC World Markets Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DNB Markets, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Regions Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>1,000,000,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>1,250,000,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>1,000,000,000</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Schedule&nbsp;I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX&nbsp;A </U></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Disclosure Package </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Pricing Term Sheet, dated May&nbsp;1, 2023, to the Preliminary Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[See Attached] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex&nbsp;A </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Filed pursuant to Rule 433 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Issuer Free Writing Prospectus, dated May&nbsp;1, 2023 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Supplementing the Preliminary Prospectus Supplement, dated May&nbsp;1, 2023 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-271537</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HCA Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$1,000,000,000
5.200% Senior Notes due 2028 (the &#147;2028 notes&#148;) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$1,250,000,000 5.500% Senior Notes due 2033 (the &#147;2033 notes&#148;) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$1,000,000,000 5.900% Senior Notes due 2053 (the &#147;2053 notes&#148;) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(collectively, the &#147;notes&#148;) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pricing Supplement </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pricing Supplement
dated May&nbsp;1, 2023 to HCA Inc.&#146;s Preliminary Prospectus Supplement dated May&nbsp;1, 2023. This Pricing Supplement is qualified in its entirety by reference to the Preliminary Prospectus Supplement. The information in this Pricing
Supplement supplements the Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Financial
information presented in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by changes described herein. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the
Preliminary Prospectus Supplement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="68%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>Terms Applicable to the 2028 notes</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>HCA Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Aggregate Principal Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>$1,000,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Title of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>5.200% Senior Notes due 2028</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Maturity Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;1, 2028</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Spread to Treasury</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>160 basis points</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Benchmark Treasury</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>UST 3.500% due April&nbsp;30, 2028</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Benchmark Treasury Price&nbsp;&amp; Yield</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP><FONT STYLE="white-space:nowrap">99-12</FONT> <SUP STYLE="vertical-align:top">1</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB> / 3.636%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Coupon</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>5.200%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Public Offering Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>99.836% plus accrued interest, if any, from May&nbsp;4, 2023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Yield to Maturity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>5.236%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Interest Payment Dates</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>June&nbsp;1 and December&nbsp;1 of each year, beginning on December&nbsp;1, 2023</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="68%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Record Dates</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;15 and November&nbsp;15 of each year</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net Proceeds to Issuer before Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$992,360,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CUSIP/ISIN Numbers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CUSIP: 404119 CP2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ISIN: US404119CP27</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Optional Redemption</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to May&nbsp;1, 2028, the 2028 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or &#147;make- whole,&#148; price equal to the greater of:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;100% of the aggregate principal amount of the 2028 notes to be redeemed,
and</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;an amount equal to the sum of the present value of (a)&nbsp;the payment on
May&nbsp;1, 2028 of principal of the 2028 notes to be redeemed and (b)&nbsp;the payment of the remaining scheduled payments through May&nbsp;1, 2028 of interest on the 2028 notes to be redeemed (excluding accrued and unpaid interest to the
redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a <FONT
STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) using a discount rate equal to the Treasury Rate plus 25 basis points</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">plus, in each of (i)&nbsp;and (ii) above, accrued and unpaid interest, if any, to such redemption date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">On and after May&nbsp;1, 2028, the 2028 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of such 2028 notes plus accrued and
unpaid interest, if any, to such redemption date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>Terms Applicable to the 2033 notes</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">HCA Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Aggregate Principal Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$1,250,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Title of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.500% Senior Notes due 2033</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Maturity Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;1, 2033</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Spread to Treasury</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">193 basis points</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Benchmark Treasury</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">UST 3.500% due February&nbsp;15, 2033</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Benchmark Treasury Price&nbsp;&amp; Yield</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">99-11+</FONT> / 3.578%</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="68%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Coupon</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.500%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Public Offering Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.932% plus accrued interest, if any, from May&nbsp;4, 2023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Yield to Maturity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.508%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Interest Payment Dates</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;1 and December&nbsp;1 of each year, beginning on December&nbsp;1, 2023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Record Dates</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;15 and November&nbsp;15 of each year</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net Proceeds to Issuer before Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$1,241,025,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CUSIP/ISIN Numbers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CUSIP: 404119 CQ0</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ISIN: US404119CQ00</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Optional Redemption</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to March&nbsp;1, 2033, the 2033 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or &#147;make- whole,&#148; price equal to the greater of:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;100% of the aggregate principal amount of the 2033 notes to be redeemed,
and</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;an amount equal to the sum of the present value of (a)&nbsp;the payment on
March&nbsp;1, 2033 of principal of the 2033 notes to be redeemed and (b)&nbsp;the payment of the remaining scheduled payments through March&nbsp;1, 2033 of interest on the 2033 notes to be redeemed (excluding accrued and unpaid interest to the
redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a <FONT
STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) using a discount rate equal to the Treasury Rate plus 30 basis points</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">plus, in each of (i)&nbsp;and (ii) above, accrued and unpaid interest, if any, to such redemption date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">On and after March&nbsp;1, 2033, the 2033 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of such 2033 notes plus accrued and
unpaid interest, if any, to such redemption date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><B>Terms Applicable to the 2053 notes</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Issuer</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">HCA Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Aggregate Principal Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$1,000,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Title of Security</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.900% Senior Notes due 2053</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="68%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Maturity Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;1, 2053</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Spread to Treasury</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">233 basis points</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Benchmark Treasury</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">UST 4.000% due November&nbsp;15, 2052</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Benchmark Treasury Price&nbsp;&amp; Yield</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">103-11</FONT> / 3.810%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Coupon</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.900%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Public Offering Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">96.718% plus accrued interest, if any, from May&nbsp;4, 2023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Yield to Maturity</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">6.140%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Interest Payment Dates</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">June&nbsp;1 and December&nbsp;1 of each year, beginning on December&nbsp;1, 2023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Record Dates</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;15 and November&nbsp;15 of each year</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net Proceeds to Issuer before Expenses</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$958,430,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CUSIP/ISIN Numbers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CUSIP: 404119 CR8</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ISIN: US404119CR82</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Optional Redemption</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to December&nbsp;1, 2052, the 2053 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or &#147;make-whole,&#148; price equal to the greater of:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;100% of the aggregate principal amount of the 2053 notes to be redeemed,
and</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;an amount equal to the sum of the present value of (a)&nbsp;the payment on
December&nbsp;1, 2052 of principal of the 2053 notes to be redeemed and (b)&nbsp;the payment of the remaining scheduled payments through December&nbsp;1, 2052 of interest on the 2053 notes to be redeemed (excluding accrued and unpaid interest to the
redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a <FONT
STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) using a discount rate equal to the Treasury Rate plus 35 basis points</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">plus, in each of (i)&nbsp;and (ii) above, accrued and unpaid interest, if any, to such redemption date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">On and after December&nbsp;1, 2052, the 2053 notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of such 2053 notes plus accrued
and unpaid interest, if any, to such redemption date.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="68%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><B>Terms Applicable to the notes</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Change of Control</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon a Change of Control Triggering Event, each Holder may require the Issuer to repurchase at 101%, plus accrued and unpaid interest, if any.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Trade Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;1, 2023</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Use of Proceeds</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">We estimate that our net proceeds from this offering, after deducting underwriting discounts and estimated offering expenses, will be approximately $3,186,000,000.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">We intend to use the net proceeds from this offering for the repayment of near-term maturities and for general corporate purposes. Prior to such repayment, we may temporarily repay borrowings outstanding under our senior secured
asset-based revolving credit facility.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Denominations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$2,000 and integral multiples of $1,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Form of Offering</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">SEC Registered (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-271537)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Joint Book-Running Managers</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">BofA Securities, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Citigroup Global Markets Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">J.P. Morgan Securities LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Wells Fargo Securities, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Barclays Capital Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Capital One Securities, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Mizuho Securities USA LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Morgan Stanley&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">RBC Capital Markets, LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">SMBC Nikko Securities America, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Truist Securities, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Co-Managers</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Credit Agricole Securities (USA) Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fifth Third Securities, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Scotia Capital (USA) Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">BNP Paribas Securities Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CIBC World Markets Corp.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DNB Markets, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">PNC Capital Markets LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Regions Securities LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Settlement Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;4, 2023 (T+3)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">We expect that delivery of the notes will be made to investors on or about May&nbsp;4, 2023, which will be the third business day following the date of this pricing term sheet (such settlement being referred to as &#147;T+3&#148;).
Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Exchange Act, trades in the secondary market are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who
wish to trade notes prior to the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially settle in T+3, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed
settlement. Purchasers of the notes who wish to trade the notes prior to their date of delivery hereunder should consult their advisors.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>The issuer has filed a registration statement (including a prospectus and a related
preliminary prospectus supplement) with the United States Securities and Exchange Commission (&#147;SEC&#148;) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement,
the preliminary prospectus supplement and other documents HCA Healthcare, Inc. has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at
www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus may be obtained from BofA Securities, Inc.,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NC1-022-02-25,</FONT></FONT></FONT> 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, by telephone <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-294-1322</FONT></FONT></FONT> or by emailing: <U>dg.prospectus_requests@bofa.com</U>; Citigroup Global Markets Inc., c/o Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-831-9146</FONT></FONT></FONT> or by emailing: <U>prospectus@citi.com</U>;
J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone:
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-803-9204;</FONT></FONT></FONT> or Wells Fargo Securities, LLC, 608 2nd Avenue South, Suite 1000, Minneapolis, MN 55402, Attn: WFS Customer
Service, by telephone (toll-free): <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-645-3751</FONT></FONT></FONT> or by emailing: <U>wfscustomerservice@wellsfargo.com</U>. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>This communication should be read in conjunction with the preliminary prospectus supplement and the accompanying prospectus. The information
in this communication supersedes the information in the preliminary prospectus supplement and the accompanying prospectus to the extent inconsistent with the information in such preliminary prospectus supplement and the accompanying prospectus.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH
DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX&nbsp;B </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">None. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex&nbsp;B </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX&nbsp;C </U></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Significant Subsidiaries of the Company </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthtrust, Inc. &#150; The Hospital Company (DE) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Galen
Holdco, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hospital Corp., LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HTI Hospital Holdings, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HCA Squared, LLC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex&nbsp;C </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXHIBIT A </U></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Opinion of Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP </U></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXHIBIT B </U></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Negative Assurance Letter of Cleary Gottlieb Steen&nbsp;&amp; Hamilton LLP </U></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXHIBIT C </U></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Form of Regulatory Opinion of Bass, Berry&nbsp;&amp; Sims PLC </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be substantially similar to the opinion given in connection with the issuance of the Company&#146;s $1,000,000,000 3 1/8% Senior Secured Notes due 2027,
$500,000,000 3 3/8% Senior Secured Notes due 2029, $2,000,000,000 3 5/8% Senior Secured Notes due 2032, $500,000,000 4 3/8% Senior Secured Notes due 2042 and $2,000,000,000 4 5/8% Senior Secured Notes due 2052, subject to such changes as are
appropriate to reflect the current terms of the Securities and as otherwise reasonably agreed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit C-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hca-20230501.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/2/2023 4:54:06 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:hca="http://hcahealthcare.com/20230501"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://hcahealthcare.com/20230501"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hca-20230501_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hca-20230501_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hca-20230501_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/2/2023 4:54:06 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hca-20230501_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/2/2023 4:54:06 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hca-20230501.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140080206376928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000860730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  01,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HCA Healthcare, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3865930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Park Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">344-9551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HCA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d900328d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hca-20230501.xsd" xlink:type="simple"/>
    <context id="duration_2023-05-01_to_2023-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000860730</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-05-01_to_2023-05-01">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-05-01_to_2023-05-01"
      id="Hidden_dei_EntityCentralIndexKey">0000860730</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-05-01_to_2023-05-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-05-01_to_2023-05-01">2023-05-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-05-01_to_2023-05-01">HCA Healthcare, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-05-01_to_2023-05-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-05-01_to_2023-05-01">001-11239</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-05-01_to_2023-05-01">27-3865930</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-05-01_to_2023-05-01">One Park Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-05-01_to_2023-05-01">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-05-01_to_2023-05-01">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-05-01_to_2023-05-01">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-05-01_to_2023-05-01">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-05-01_to_2023-05-01">344-9551</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-05-01_to_2023-05-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-05-01_to_2023-05-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-05-01_to_2023-05-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-05-01_to_2023-05-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-05-01_to_2023-05-01">Common Stock, $.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-01_to_2023-05-01">HCA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-01_to_2023-05-01">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-05-01_to_2023-05-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M $JB5GRQV/ON    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @  $JB5IE<G",0!@  G"<  !,
M ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "   2J)6*C-W
M24H$  "%$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @  $JB5I^@&_"Q @  X@P   T
M ( !C0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "   2J)6EXJ[',     3
M @  "P              @ %I#P  7W)E;',O+G)E;'-02P$"% ,4    "
M2J)6'#AEZC\!   \ @  #P              @ %2$   >&PO=V]R:V)O;VLN
M>&UL4$L! A0#%     @  $JB5B0>FZ*M    ^ $  !H              ( !
MOA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @  $JB
M5F60>9(9 0  SP,  !,              ( !HQ(  %M#;VYT96YT7U1Y<&5S
;72YX;6Q02P4&      D "0 ^ @  [1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d900328d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d900328d8k.htm">d900328d8k.htm</File>
    <File>d900328dex11.htm</File>
    <File>hca-20230501.xsd</File>
    <File>hca-20230501_lab.xml</File>
    <File>hca-20230501_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d900328d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d900328d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hca-20230501_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hca-20230501_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hca-20230501.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hca",
   "nsuri": "http://hcahealthcare.com/20230501",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d900328d8k.htm",
      "contextRef": "duration_2023-05-01_to_2023-05-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d900328d8k.htm",
      "contextRef": "duration_2023-05-01_to_2023-05-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://hcahealthcare.com//20230501/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-23-131536-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-131536-xbrl.zip
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M,/:5Z9&T<4+J-VU2+!5RT'&7=,"[9.]+LCM@RDW8$V?P&0PA6$/[7RS6,V;
MT $WEF5ZHU<PRC1K%"/',!/_QL34:&!.^#>.5BP7<L&(1PD(^:XGKZPG]Y*A
M]<=R<%W&ARY>0F2X>X3P#]*7C<(+7,N:";9%2K');VRA8U:VF.X=[5?+@C'?
M]>SMZ%E3*9_)=VT[L+:56+:<-O>K;>&86VO;OB/!!!H-0BXF(6A+,@=Z(,<"
M"3?0-$1Q&*QV?=CU]L^JW@NH7C$CO44&9<UJ5VC.08]PN_B09E#J; Y)W:9*
MO=;)R%.9>.!3^*ZDJ+P'/WSO3$?0E%:O5@_QC>Y75%>L!9R%ONW@NR<< K8
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MY\P>; X?)LZ054^1DC1:5RPV*A;.YZN/BL8YVO-$^ST^H>R1CS[%/D*&O8[
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M]$"2>51.5P&7QUX>L1\GB6]C7_$^]Q#0+(*FBWSPEZCTWZFJ_1]02P,$%
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M3S-XZT&0I7&4!.W6]FM0'Y9^ E\ T^";(!EXGT".Q.$H3-XN_:VD_P/?\KW
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MW@,PLH_.GIP+[@,B$"/&303RH!>RA!AXXTF63P!%\20"KQ?D\ N97Y,,1/
M*&?@=2>7D[RPC/@._-<EC7VX$35ON=.AS5$*K!JO%J'E>RCM/H=!7%SU WQ-
M6?)YMN!36"5WXV-?OLM1AL&[2LLXY2^%[-+,X7[ZZ1<9;$<]C_@."(1^F.?
M   ,7X(;N+;'.RE=#$Q#:83P1*3I G]' E=RI1^,@WY43$OD?<'7.2O"K1V&
MDR('.>3M!\GWTMNZHS"+^D'NLZ2[C/(B"T"^CH,IB;]+W"S!![:;#Y&$+JM
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M5F2:M5M@[0-MX1;IBP';.Z/@.ZL=^O6YNLM7*!=COKC"I'Z4@44$5Q/UL>G
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M<S=0[6 D6*KV_N1:S,E6X<;^4FM!2>S. J_1:PJ,J"Y$BQ++-M<0R2.KQ^,
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MW,?F=WHN(#$U.Z^^.LI&WG2L=8538+ JV(_W=]T,<IW6\.8E4 $WX?@2W"R
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MKY-O!OB%@EJD$D!,Y@GQXW(>%BA],0UJM STV0X ;P'[W[.:\W.!7=G_L7S
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M$AO.K4!02-V<!-HZ_%HW&4E5K=DSQS!(QA2E@M+8A)CS)W5%G=O15^4'N%:
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M?%YGZR]:'YVYI-ISN1TJE#Q@]3F?2%816TL[+[VK=)+IGLYR@-RQ%.DU2&3
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MNNST\*/'U?GKXHZQ[K17X+Z[]#)5*L%/XBEIE PJQ;.^\<=(XU>,EB7U]=2
M)^6<:BDZ$#6"2A<!9_S&W&\^HB2U)2FZQ1CZ)4+5Q*>B#$S/F?TQ*%1;M_ '
MOBY7C8/4'**ZE=A5ON37'1"%4TL"JU?%.]W,P<?A# C($@JI*G,]!L4W]6[E
M*6S59?!T>[-: 0+A0QT8ZL%::Z*0^F"/:ZL%J]J+;,X#/' GTNIV7%H+%"NG
MP8E.[ZM]E:E3D-D+V(T44[2D9XXA+,6=?,TB;:91*I-6?L:U'^L2*W?(P8F+
M5G.7IXZY?ZB+"516LRHO\(V_W1<L0<:M#3VKCX:R^N!7($.&9NAKX]!JFN%3
MF$^<_TC@#B]3C7.E/*5^G;SCBFA3.0)X@-/UZE7Z5.3"DO"1('M>SB8<^98&
MC<.4X-PZ>]ZW\P.)GK^BT?/87TB+&H(;-LS@%C880L2'P;^/H'XT#YT']>,S
MSX#)3?A!M6&3Z3 R!U3-W\RXTX,6C7UQKQII#H@ U,V!*^&.>9%-^MI\2(>/
M (29(^X/,8V$B\(-'+B\C-(LF&2I]T["X*@4U?B\^W:KBD^1N/>>\4BW[9V5
M"^.!ZHQT>DNW;Z?Z,.T@SI1CJ%T. '?>[.QP+@[S%M,]+)O$H30WL)-(3,1/
M=0R9E59R#V*\!PAJ<KOKN;*:+\:D=P8[EE#85@>$-<UJ.--[YY\.'W-CBBTT
MG7"4NVUO@H>+P]UCU<:9<>%F6%EKWWV[N^6=_NI[1T$.));0I1Z%#:92*N![
MVUO;.X^Y$[O.LWX;W.K'F104>.>H'@S0W(:_X7P"*6%BB_0J!4M4?45_Z/DV
M."XJHZ0,G<]BS47@ '2&+;CZY!?4'9[5U(,!#PV01D(]GD./35%BG"4!&*\=
M_@>1;DC\&( UW*21=U$'*9T  CQ*YR>9FQ]Q!W:3FX7XK],5AQGQ;BTC!O:K
M.+'WS!CQ,>55D+-$>:YG@L=<;\J@-7AVM^;(J><&'6P/' TBL/ -1-HMMJ[X
MHG-]A4E4-KG),ZJ]&\<+UJ1#F3K!?C!FX/';#\.\GT5CNV;Y),5R/EG,X_'A
M"V)ZQ_08W-U,I*JY6.CMS;T0BH:U-6/4<U3'=U?J^ .AZK&JF],#??.:G'EO
MFDZD(%V[!0'/\,O 6(!CGH^ W@.EC@,BDYMP(OF<"4GT@3>8D*I5A-J50^W-
MQ=\$:XC#HA /,[W;\M.J]@UJ.EB@@Y8FWMX+BYLP3&ICD:J1GQUTKRIK%A2W
M;UE80\<L>$ QQ!=6K4VY!*9<(N,@DU5*\Z U.A\0*[G>YH/\8>II7O[E!1>"
MZ%]4)0QO5WZM%-K,ODEO["^U]^^^4M]3^8E9G]IX0S60=\N-EQ9'M3WV<LI;
MK586E?<%)P#G>4+\X>3K;V?=TP__0,<Z*+SQE) W]\W&W$U9J[,6]_D((X(
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MSGS>Y$B(\A)\U;8#^3]LA=Q$!Z7I88-];')SQOZS#P%BRS]02P$"% ,4
M"   2J)6O MFP5,0   1;@  #@              @ $     9#DP,#,R.&0X
M:RYH=&U02P$"% ,4    "   2J)6XT6EOP2   "_50, $
M@ %_$   9#DP,#,R.&1E>#$Q+FAT;5!+ 0(4 Q0    (  !*HE939WG&0 ,
M $L+   0              "  ;&0  !H8V$M,C R,S U,#$N>'-D4$L! A0#
M%     @  $JB5AJ'LQ1;!@  O4,  !0              ( !'Y0  &AC82TR
M,#(S,#4P,5]L86(N>&UL4$L! A0#%     @  $JB5GOJZ,6T!   ?"H  !0
M             ( !K)H  &AC82TR,#(S,#4P,5]P<F4N>&UL4$L%!@     %
-  4 / $  )*?      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
